Evidence map›Paper›PMID 27771943›Full record

ReviewBritish journal of pharmacology2017

Synaptic Zn

Christopher A Reid, Michael S Hildebrand, Saul A Mullen, Joanne M Hildebrand, Samuel F Berkovic, Steven Petrou

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in British journal of pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Prenatal Zinc Deficient Mice as a Model for Autism Spectrum Disorders.International journal of molecular sciences · 2022
    Review
  5. Neurology international · 2021
    Article
  6. Zinc in the Brain: Friend or Foe?International journal of molecular sciences · 2020
    Review
  7. Review
  8. The Zinc Sensing Receptor, ZnR/GPR39, in Health and Disease.International journal of molecular sciences · 2018
    Review
  9. Review
  10. Synaptic ZnBritish journal of pharmacology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Christopher A ReidFlorey Institute for Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia.
Michael S HildebrandEpilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, VIC, Australia.
Saul A MullenFlorey Institute for Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia.
Joanne M HildebrandCell Signalling and Cell Death Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Samuel F BerkovicEpilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, VIC, Australia.
Steven PetrouFlorey Institute for Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia.
University of Melbourne · AUAustin Health · AUFlorey Institute of Neuroscience and Mental Health · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zn

Indexed as

AnimalsHumansSeizures, FebrileSynaptic VesiclesZincZinc

Identifiers

PMID27771943
PMCPMC5192799
OpenAlexW2540186744

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.